Drug
Elamipretide
Elamipretide: highest development phase Phase 1, developed by Stealth BioTherapeutics Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Stealth BioTherapeutics Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elamipretide NCT07927972 | Phase 1 | Barth Syndrome |
Latest
No recent events.
Follow Elamipretide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.